How does the safety profile of ixekizumab compare to other IL-17 inhibitors?Featuring Saakshi Khattri , MD | Assistant Professor of DermatologyIcahn School of Medicine at Mount SinaiNew York, NY | Published August 20, 2024Loading...Related MediaPowered by Polaris TM